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Genetic Predisposition to Depression
Abstract
Bechu, Elsa The Role of Single Nucleotide Polymorphisms Causing a Dysregulation of the
HPA Axis on the Incidence of Depression. Department of Biological Sciences, 2021.
Advisor: Brian Cohen
Depression is one of the most prevalent diseases worldwide, afflicting approximately 17

million adults in the US in 2019. A prominent causal factor of depression is dysregulation of our
body’s response to stress when exposed to continuous stressors over long periods of time. Stress
is regulated by the Hypothalamic-Pituitary-Adrenal (HPA) axis, with cortisol as its effector
hormone. The effects of cortisol are exerted through the glucocorticoid and mineralocorticoid
receptors (GR and MR, respectively) in the body and the brain, respectively. The HPA axis is
regulated by a negative feedback loop where activation of the GR by circulating cortisol inhibits
the production of additional cortisol.
Our lab investigated the role of single nucleotide polymorphisms (SNPs), or mutations, in
the genes of the MR, GR, and associated regulatory proteins that are hypothesized to be involved
in the dysregulation of function leading to hypersensitivity or resistance to cortisol in the HPA
axis. Previous literature has demonstrated that prominent GR and MR SNPs correlate with higher
incidence of depression and/or depressive symptoms. Our study continued this investigation into
the relationship between mutations and depression in a clinical sample of psychiatric patients
from Albany Medical College. We were especially interested in the interplay between mutations
of the GR and MR influencing cortisol levels and response in our bodies. DNA from patients
was collected with buccal swabs and genotypes were analyzed through allele specific and
quantitative polymerase chain reactions. We compared genotypes to the Beck Depression
Inventory (BDI) score of patients, as well as other scales measuring anxiety and mood. No
significant two-tailed correlation between individual SNPs or GR/MR SNP combinations and
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BDI scores was found. One SNP in the GR gene (rs33389) and one SNP on the 11ßhydroxysteroid dehydrogenase type 1 (rs12086634), an enzyme that regulates peripheral cortisol
levels, demonstrated significant one-tailed correlations with the Mindful Attention Awareness
Scale and State Trait Anxiety scale, respectively. Obtaining a greater sample size would yield
more representation of mutant alleles and potentially allow for more significance correlating
genetic mutations to the incidence of depression.
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The Role of Single Nucleotide Polymorphisms Causing a Dysregulation of the
HPA Axis on the Incidence of Depression
In 2017, an estimated 262 million people, or 3.4% of the global population, were
diagnosed with depression, making it one of the most prevalent diseases worldwide. In the
United States alone, depression is the prominent causal factor of disability for people aged 15-44
(Ritchie and Roser, 2018). Depression manifests itself through a variety of different symptoms
(figure 1), and the number, severity, and duration of symptoms can vary widely between patients.
Multiple factors can contribute to the onset of depression, including personality traits and
environmental factors, though most changes brought on by depression are a result of altered
biochemical processes in the body (Torres, 2020). A prominent theory is that depressive
symptoms are a result of our body’s repeated response to stress; when stressors become
continuous or consistent over long periods of time is when depressive symptoms tend to arise
(Deak, 2016).

Figure 1. Symptoms of Major Depression. Taken from Cohen, 2020.
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Stress is regulated in our bodies by the Hypothalamic Pituitary Adrenal (HPA) axis, and
its effector hormone, cortisol, is commonly labeled as the stress hormone (Deak, 2016). The
HPA axis is composed of three cell populations in the hypothalamus, pituitary, and adrenal
glands that communicate through the release of hormones, ultimately having metabolic effects
on the body (Figure 2). When an environmental stressor is present, corticotropin releasing factor
(CRF) neurons in the hypothalamus receive neural input from multiple brain regions, causing
them to increase activity and produce and secrete the CRF hormone. This CRF hormone then
travels to the pituitary gland and induces activity in corticotroph endocrine cells in the anterior
pituitary. These cells produce and release adrenocorticotropic hormone (ACTH). ACTH migrates
to the adrenal cortex where it binds to the melanocortin 2 receptor, inducing the conversion of
cholesterol to cortisol through a sequence of enzyme-mediated reactions. The HPA axis is
regulated through a series of negative feedback loops (Deak, 2016).
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Figure 2. Simplified diagram of the HPA axis and its components. CRF neurons in the
hypothalamic paraventricular nucleus receive neural input due to some kind of stress, triggering
the production and release of the CRF hormone, which travels to the pituitary gland.
Corticotrophs in the pituitary gland secrete ACTH, and endocrine cells in the adrenal gland
secrete cortisol. Cortisol is released into systemic circulation, reaching cells throughout the body
and brain. Cortisol also induces direct negative feedback inhibition to the pituitary gland and
hypothalamus. Taken from Endocrine Physiology, Fourth Edition (Molina, 2013).

Cortisol is a glucocorticoid and the main effector hormone of the HPA axis.
Glucocorticoids are steroid hormones that are involved in multiple physiological functioning’s
necessary for daily life. Glucocorticoids’ main function is the regulation of metabolism, and
secondary functions include the control of the inflammatory response and regulation of cognitive
functions such as learning and memory (Gomez-Sanchez and Gomez-Sanchez, 2014;
Timmermans et al., 2019). Cortisol release impacts metabolism by increasing blood pressure as
well as increasing blood sugar by stimulating gluconeogenesis, and suppresses the immune
response (Timmermans et al., 2019). Cortisol is the human glucocorticoid and exerts its effects
through glucocorticoid and mineralocorticoid receptors (GR and MR receptors, respectively).
The GR and MR are intracellular receptors that function as transcription factors after ligand
binding. In their unbound form, the GR and MR are part of a multiprotein complex located in the
cytoplasm, including chaperone proteins and immunophilins. Once cortisol binds, the receptors
undergo conformational changes leading to dissociation from the protein complex and migration
into the nucleus, where they regulate gene expression (Deak 2016; Moraitis et al., 2016). The GR
is abundantly expressed in most cell types across the body, while the MR is expressed
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predominantly in only the hippocampus, amygdala, prefrontal cortex, and kidneys (Koning et al.,
2019; Deak, 2016). The MR has a high affinity for glucocorticoids and is normally bound at low
basal levels of cortisol, whereas the GR has a low affinity for glucocorticoids and is normally
occupied only under elevated cortisol levels (such as due to a stressor), and is therefore more
responsive to small changes in glucocorticoid concentrations (DeRijk et al, 2006; Chen et al.,
2016; Deak, 2016).
The activation of GR and MR are crucial for normal responses to stress; the receptors
control processes regulating cognition, mood, and behavioral responses (Koning et al., 2019).
When stressed, the activated MR aides in retrieving memory and appraisal processes, while the
activated GR promotes consolidation of memory as well as energy redistribution to stop the
stress response (Koning et al., 2019; Chen et al., 2016). Subsequently, proper functioning of the
HPA axis is necessary for appropriate responses to stress. Dysregulations in the HPA axis,
specifically in the activity of GR, MR, and circulating cortisol, have been theorized to contribute
to improper responses to stress, and consequently, depression (Pariante, 2010; DeRijk et al,
2006; Chen et al., 2016; Plieger et al., 2017; Moraitis et al., 2016). This hypothesis is partially
based on diseases of under- and over-production of cortisol, Addison’s Disease and Cushing’s
Syndrome, respectively (Figure 3).

Genetic Predisposition to Depression

5

Figure 3. Common symptoms of Addison’s and Cushing’s syndrome.

Addison’s Disease is characterized by insufficient production of aldosterone and cortisol,
and symptoms can include irritability and depression (Rare Diseases, 2018). On the other end of
the spectrum, Cushing’s syndrome is characterized by excess cortisol production by the adrenal
glands, and presents symptoms including mood dysregulation and depression (Pariante, 2010;
Tang et al., 2013; Chen et al., 2016). These disease states demonstrate that differences in
circulating cortisol, hypo or hypercortisolemia, can lead to depressive symptoms. Many patients
with psychiatric disorders have been shown to express diminished HPA axis negative feedback
regulation, demonstrated by elevated cortisol levels (Pariante, 2010). Unlike Cushing’s and
Addison’s, in which elevated or reduced cortisol levels affect brain function through normally
working GR/MR receptors, studies into depression exhibit altered cortisol responsiveness due to
impaired functioning receptors (Pariante, 2010). Pariante and Miller measured GR function in
vitro and in vivo and found that depressed patients have a diminished GR response when
compared to healthy controls (2001). This diminished GR capacity is hypothesized to arise from
either impaired function or decreased expression of GR in the brain (Pariante, 2010). Impaired
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GR functioning is commonly referred to as glucocorticoid resistance, as the GR is unable to
respond effectively to circulating cortisol, and this leads to elevated cortisol levels in the body.
Other studies have also theorized that glucocorticoid resistance, stemming from GR impairment
or lack of expression, is a key factor in the development of depression (Juruena et al., 2003;
Rodriguez et al. 2016). Interestingly, both GR agonists and antagonists have displayed
antidepressant effects, and some studies have also demonstrated overactivation of the GR as a
risk factor in depression (Pariante, 2006; Koning et al., 2019). Lack of function and/or
expression in the MR receptor has also been linked to depression; Medina et al. found that
depressed patients had reduced MR expression in the anterior hippocampus, and Lopez et al.
found reduced MR expression in the prefrontal cortex of depressed patients (2012; 1998).
Although often theorized to arise from chronic stress, depression does not impact all
individuals who face chronic stress problems or traumatic events, nor do all depressed patients
have impaired GR/MR receptor functioning. This has led to many theories on what increases an
individual’s chance at developing depression in the face of stress (Cohen, 2007). A prominent
area of investigation is genetics based on the heritability of depression; if one of two identical
twins has depression, there is up to a 70% chance the other will develop depression in their
lifetime, and heritability of depression if a first degree relative was diagnosed is increased two to
threefold (Torres, 2020; Lohoff, 2011). Mutations in the genes of the MR and GR, resulting in
hypersensitivity or hyposensitivity to cortisol (depending on whether the mutation causes
overstimulation or understimulation of the HPA axis in response to normal levels of cortisol,
respectively) have been thoroughly investigated for possible links to depression. Such mutations
result in a dysregulation of the HPA axis, and consequently, may demonstrate a higher likelihood
for depressive symptoms. Mutations appear in the form of single nucleotide polymorphisms, or
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SNPs. The NR3C1 gene codes for the GR receptor, and multiple polymorphisms along this gene
have been associated with altered cortisol levels as well as depression (Plieger et al., 2017;
Moraitis et al., 2016; Cohen et al., 2007; DE Rijk et al., 2006). Thoroughly investigated SNPs of
the GR gene include the Bcl1 (rs41423247), the TthIII (rs10052957), the N363S (rs1800445),
and the combined ER22/23EK (rs6189, rs6190) polymorphisms. The Bcl1 polymorphism major
allele has been associated with increased responsiveness to cortisol (Van Rossum and Lamberts,
2004), and Plieger et al. found that minor allele carriers had significantly higher cortisol levels
following acute stress (2017). The ER22/23EK polymorphism carriers displayed glucocorticoid
resistance, and all carriers of this polymorphism also carried the TthIII minor allele (Moraitis et
al. 2016). On the other hand, Van Rossum and Lamberts reported a GC resistance in ER22/23EK
carriers, but no association with altered GC sensitivity in carriers of the TthIII polymorphism
(2004). The N363S polymorphism was found to increase sensitivity to GCs (Moraitis et al.,
2016). Thoroughly investigated SNPs of the MR gene include the MR I180V polymorphism
(rs5522) and -2G/C (rs2070951) (van Leeuwen et al., 2011; Plieger et al., 2018; Klok et al.,
2011). Klok et al. found that a haplotype consisting of the minor allele of -2G/C and the major
allele of MR I180V caused an increase in MR activity, improving resilience to depression and
fewer thoughts of hopelessness, especially in women (2011). We are interested in studying SNPs
related to GR, MR, and regulatory protein functionality in order to determine hyper/hypo
sensitivities to cortisol and potential predispositions to depression. SNPs of interest and their
reported effects are listed in Table 1.
SNP

Common Name

Gene

Effect (of minor
allele)

rs41423247

Bcl1

NR3C1

Hypersensitivity
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rs10052957

TthIII

NR3C1

Hyposensitivity
(resistance)

rs1800445

N363S

NR3C1

Hypersensitivity

rs5522

MR I180V

NR3C2

Hyposensitivity
(resistance)

rs2070951

-2G/C

NR3C2

Hypersensitivity

rs33389

rs333

NR3C1

Hyposensitivity
(resistance)

rs10515522

rs105

NR3C1

Hypersensitivity

rs12086634

rs120

11β-HSD1

Hyposensitivity
(resistance)

rs1360780

FKBP51a

FKBP51a

Hypersensitivity

Table 1. SNPs of interest in our study and the gene on which they are located, as well as the
effect of the minor allele.
Rs33389 and rs10515522, though less thoroughly investigated than the previously
mentioned GR polymorphisms, were in a haplotype associated with elevated response to cortisol
following acute stress by Plieger et al. (2017). The haplotype consisted of the minor allele of
rs33389 and the major allele of rs10515522, among other SNPs (Plieger et al., 2017).
Rs12086634 is a polymorphism along the gene coding for 11β-HSD1, which converts cortisone
to the active form of cortisol. A reduction in the level and/or functioning of 11β-HSD1 has been
found to protect hippocampal function from elevated cortisol levels (Deak, 2016). The
rs12086634 polymorphism has been studied in relation to metabolic syndrome; Farag et al. found
that in their sample of patients, with the skin diseases acne vulgaris (AV) and skin tags (STs), the
GG genotype of rs12086634 was associated with elevated cortisol levels (2019). FKBP51 is a
co-chaperone protein that regulates GR activity in its response to stress; it is a member of the
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multiprotein complex that exists when the GR is in its unligated form (Deak. 2016). The T allele
of rs1360780 has been found to increase FKBP5 induction by cortisol, allowing the GR to be
more sensitive to cortisol (Binder et al., 2004).
We aimed to investigate these polymorphisms associated with hyper and hyposensitivities to cortisol on the HPA axis and their association with the incidence of depression.
We collected DNA samples and Beck Depression Inventory scores from patients at the
psychiatric division of Albany Medical college. Through genotyping of samples, we compared
single nucleotide polymorphisms with the presence of depressive symptoms to determine
associations between mutations and depression. Understanding the impact of certain SNPs will
aid in better comprehending the mechanisms by which dysregulation of stress, and subsequently
depression, is caused in the body. Consequently, this understanding will potentially lead to better
solutions and medications for the treatment of depression.

Methods
Participants and Inventory Tests
Forty-three patients from the Albany Medical College Psychiatric unit provided their
DNA for our study. To protect the anonymity of patients, Albany Medical College did not
release the sex or age of our participants, although all patients are adults 18 or older who
consented to provide their DNA. In addition to DNA collection, patient’s scores on four
inventory tests were provided to our lab: the Beck Depression Inventory (BDI), the State Trait
Anxiety Inventory (STAI), the Adverse Childhood Experiences test (ACE), and the Mindful
Attention Awareness Scale (MAAS). All 43 patients filled out the STAI, 40 filled out the BDI,
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23 filled out the ACE test, and 29 filled out the MAAS. All inventories are self-reported
measures of attitudes and symptoms associated with psychological disorders.
The BDI has 21 items and is a measure of depressive symptoms experienced in the last
week. Each item provides four options associated with a number score, and the total score infers
the severity (or lack thereof) of an individual’s depression. Scores range from 1 to 63 (0-3
possible points per question), with any score over 40 signifying “extreme depression” (Beck,
1961).
The STAI measures both state and trait anxiety often used to diagnose anxiety and
differentiate it from depression. There are 20 items measuring state anxiety and 20 items
measuring trait anxiety, with each item being scored from 1 to 4 depending on the extremity at
which the patient agrees with the statement (Spielberger, 1968). In our study, we used the
combined STAI scores: the total of both the state and trait anxiety scales.
The MAAS measures a patient’s mindfulness and awareness in the present moment and
consists of 15 items. Each item is scored from 1 to 6, and higher scores indicate higher
mindfulness and awareness (Brown and Ryan, 2003).
Finally, the ACE questionnaire measures different categories of adverse experiences in
childhood in an attempt to predict future health and behavioral risks. The inventory has 17
questions split into seven categories with responses of ‘yes’ or ‘no,’ and an answer of yes to at
least one question representing exposure to those types of adverse experiences (Felitti et al.,
1998). Participants provided cortisol samples at the time of their visits to the psychiatric center,
but the lack of uniformity in collection times and the likely cortisol fluctuations influenced by
circadian rhythms prevented us from utilizing the samples and analyzing the data in an accurate
manner.
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DNA Collection and Extraction
DNA collection was achieved through self-administered buccal swabbing at Albany
Medical College. Samples were collected between January and December of 2018. Once
collected, DNA was sent to our lab at Union College for extraction. DNA was stored at 4 degrees
C for 1 to 10 days before extraction. Extraction procedures are listed in appendix 1. Once
extracted, DNA was stored at -20 degrees C and defrosted for genotype analysis.
The delay in DNA extraction for some samples may have been a contributing factor to
the lack of results when undergoing genetic analysis. DNA samples that did not display results
through allelic or quantitative PCR (polymerase chain reaction) went through a purification step
using Chelex to remove non-genetic material from the samples. The Chelex prep method is listed
in appendix 1.

Genotype Analysis
Genotype analysis was conducted through two methods: allelic polymerase chain reaction
(allelic PCR) and quantitative polymerase chain reaction (qPCR). Allelic PCR was performed to
genotype the Bcl1, TthIII, rs207, N363S, rs120, and FKBP51a polymorphisms, while qPCR was
conducted to genotype rs5522, rs33389, and rs10515522.
The polymerase chain reaction is a DNA amplification method utilizing the DNA
replication mechanism of DNA polymerase. Forward and reverse primers are used to identify
and amplify selected regions of DNA, and billions of copies of the desired DNA are produced by
the end of the reaction (NCBI, 2017). This reaction is done in vitro and the results are analyzed
using gel electrophoresis. Gel electrophoresis is performed to separate DNA fragments according
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to size. Negative electrical currents are pumped through the gel, causing the positively charged
DNA fragments to repel the charge and move down the gel. The extent of the movement is
governed by the size of the fragment. A dye is used to stain the DNA and make the bands visible.
Because we selected forward and reverse primers, the approximate size of the expected bands for
our product is known. Allelic PCR was run on two tubes per sample: one with a WT primer and
another with a MU primer (both contain a common primer). Each PCR product was placed in a
separate well and run on the gel; presence of a band in only the WT or MU column signified a
WT or MU genotype (respectively), and a band in both columns signified a Heterozygote. An
example of a gel is shown in appendix 1. Gels were visualized using the ImageLab application
on a desktop computer.
qPCR, or quantitative PCR, measures DNA amplification in real time with fluorescence
measurements (New England Biolabs, N.D). To run the reaction, a DNA template is mixed with
DNA polymerase, free deoxynucleotides (dNTPs), and primer sets (similar to conventional
PCR). In order to achieve these real time amplification measurements, qPCR has two elements
that are not present in conventional allelic PCR: fluorescent dye and a fluorometer. Fluorescent
reporter molecules in each reaction cause an increase in fluorescence with each amplification of
DNA, and the increasing fluorescence is measured by the fluorometer. qPCR real time results are
depicted on an amplification plot, measuring cycle number on the x axis and fluorescence on the
y axis. Threshold for fluorescence is provided, and a positive result for that primer set is obtained
once amplification exceeds the threshold (New England Biolabs, N.D). Protocols for all
procedures are listed in appendix 1. Genotypic results for the qPCR were identified using allele
amplification and discrimination plots on the ThermoFisher Quant Studio application. Allele
amplification plots demonstrated the presence or lack of amplification for specific alleles, and
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the allele discrimination plot utilized an automatic threshold value to deduce if amplification
values were demonstrative of the presence of the desired allele. Examples of both plots are listed
in appendix 1.

Data Analysis
Allelic and genotypic frequencies were determined on excel by calculating the number of
WT and MU alleles per SNP. Each patient had two alleles: WT genotypes contained 2 WT
alleles, heterozygous genotypes contained 1 WT and 1 MU allele, and MU genotypes contained
2 MU alleles. WT and MU alleles were divided by total alleles for each SNP to determine allelic
frequency.
Data was analyzed using IBM SPSS and JMP Pro softwares. Inventory scores (BDI,
STAI, MAAS, and ACE) were individually compared to genotypes of single SNPs as well as
combinations of SNPs (haplotypes). Patient IDs, genotypes, and inventory scores were entered
into SPSS and JMP softwares. Although three genotypes were present in the sample (WT,
Hetero, and MU), SNPs were divided in two groups for statistical analysis: WT and Hetero/MU.
The majority of SNPs did not have enough mutant and/or heterozygous samples to compare to
WT groups in ANOVA statistical analyses without introducing a high probability of error.
Rather, independent samples t-tests were conducted to compare inventory scores between the
two genotype groups in SPSS. In JMP, the Fit Y by X function was used with the SNP genotypes
as the X value and inventory scores as the Y value. Analyses were then performed using the
Means/Anova/Pooled t function to determine significance.
In addition to the effects of individual mutations, we investigated the impact of
haplotypes consisting of two SNPs. Each haplotype was composed of SNPs with opposing
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effects on the GR and MR: one SNP causing hypersensitivity of a receptor (ex. GR) and the
other causing hyposensitivity of the other receptor (ex. MR). The SNP combinations we studied
are listed in Table 7. FKBP51a is not on the GR gene, but is on the gene of a protein regulating
GR activity and was therefore included in the analysis. Two groups (labeled 1 and 2) were
created for each combination of SNPs. Group 1 consisted of a WT allele in one or both genes.
Group 2 consisted of a Hetero or MU allele in both genes. For example, a WT Bcl1 and Hetero
or Mu rs55 haplotype would be in Group 1, as would a WT Bcl1 and WT rs55 haplotype,
whereas a Hetero (or MU) Bcl1 and Hetero (or MU) rs55 haplotype (a total of 4 different
possible haplotypes) would be in Group 2. These groupings were created to pair the presence of
minor alleles across both SNPs and compare this to patients without a minor allele in both genes.
The SNP combinations were analyzed in SPSS; independent samples t-tests were conducted
between groups 1 and 2 for each SNP combination for each inventory in SPSS.

Results
Allelic Frequencies
Frequency percentages for each genotype in our sample population are recorded in Figure
7. Wildtype genotypes represented the majority of the study sample across all SNPs, ranging
from 42.86% (Bcl1) to 92.68% (N363S) of patients. Homozygous mutant genotypes for the
N363S and rs5522 alleles were not detected. In addition to genotype frequencies, the allelic
frequencies for our population were calculated and compared to the general world population
(Table 2). The World population was utilized because demographic data was not collected from
the study participants and we therefore cannot make assumptions about ethnicity. World
frequencies were reported from the NCBI dbSNP library, though N363S did not have frequency
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data. All SNPs except Bcl1and rs33389 had larger WT frequencies than the world population
data. Rs207 and rs105 had the largest disparities in allele frequencies, with the world populations
having larger WT frequencies by 0.365 and 0.240, respectively. The rs33389 sample frequencies
most closely matched that of the world population, with a 0.016 lower sample WT frequency
when compared to world frequency. The method by which allelic frequencies are calculated did
not allow for a simple t-test to be performed to determine if our sample was statistically
significant from the world population.

Individual SNP analysis
Each SNP was analyzed for correlation between genotypes and scores on inventory scales
that are associated with depression. The scales filled out by participants included the Beck
Depression Inventory (BDI), the State Trait Anxiety Inventory (STAI), the Adverse Childhood
Experiences (ACE) Scale, and the Mindful Attention Awareness Scale (MAAS).
BDI scores compared between genotypes are displayed in Table 3. No individual SNPs showed
significant correlation with BDI scores. STAI sum scores compared between genotypes of each
SNP are displayed in Table 4. No GR or MR SNPs were correlated with STAI-sum scores, but
the minor allele of rs120 (the Hetero/MU group) was significantly correlated with lower STAI
sum scores in a one-tailed t-test (t(31)= -1.74, p=0.046) (Figure 8). ACE sum scores compared
between genotypes of each SNP (Table 5) demonstrated no significant correlations, though a
one-tailed test revealed significantly higher ACE sum scores for Hetero/MU genotypes of
rs33389 (t(18)=2.04 , p= 0.028) (Figure 9). MAAS scores did not differ significantly between
genotypes of any individual SNPs (Table 6), though rs120 neared two-tailed significance (t(26)=
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2.02, p=0.053), and a one-tailed test demonstrated that Hetero/Mu genotypes displayed
significantly higher MAAS scores (t(26)= 2.02, p=0.027) (Figure 10).

SNP Combination analysis
The investigated SNP combinations are listed in Table 7. SNPs were selected by pairing
opposing effects of the different receptors, i.e. hypersensitive GR and hyposensitive MR and vice
versa. The combinations theoretically have a more pronounced dysregulation of the HPA axis
and cortisol regulation when compared to the actions of individual SNPs. For BDI, group 2
contained zero patients for Bcl1 and rs55, rs207 and rs333, N363S and rs55, and rs105 and rs55.
The SNP combinations with patients in both group 1 and group 2 displayed no significant
correlations of minor alleles and BDI score (Table 8). STAI sum scores had no significant
correlation between groups of any SNP combination (Table 9), and rs207 and rs333, as well as
N363S and rs55 did not have any patients in group 2. Bcl1 and rs55, Rs207 and rs333, N363S
and rs55, and rs105 and rs55 did not have patients in group 2 for comparison of ACE scores, and
no other minor allele group showed significant correlation with ACE sum scores (Table 10).
Comparison of MAAS scores between haplotypes also did not demonstrate any significant
correlation, and no data for group 2 was present in Bcl1 and rs55, Rs207 and rs333, N363S and
rs55, and rs105 and rs55 (Table 11).

Discussion
The focus of this study was to assess the relationship between single nucleotide
polymorphisms dysregulating HPA axis function and depressive symptoms. We investigated
mutations of the GR and MR receptors, which regulate the activity of cortisol in our brains and

Genetic Predisposition to Depression

17

bodies. Our analysis was separated into two areas: the effect of individual SNPs, and combined
effects of multiple SNPs (haplotypes) on different genes.
The GR SNPs studied were Bcl1 (rs41423247), TthIII (rs10052957), N363S (rs1800445),
rs33389, and rs1051552. The mutations caused by these single nucleotide changes have
previously been shown to demonstrate either reduced or overactivity of the GR, leading to
elevated or decreased levels of cortisol in the body, respectively. Pariante and Miller noted
diminished GR capacity leading to elevated cortisol levels in depressed patients versus healthy
controls, whereas other studies have reported lower levels of cortisol in depressed patients when
compared to healthy controls (Pariante and Miller, 2001; Huber et al., 2006). In addition, both
GR agonists and antagonists have demonstrated antidepressant effects (Pariante, 2006). Due to
the lack of consensus in previous studies, SNPs causing both an overactivation and under
activation of the GR were selected for analysis. Although no two-tailed significance was found
between polymorphisms and inventory scores, three instances of one tailed significance were
observed: the rs33389 polymorphism was significantly correlated with higher ACE scores, and
the rs120 polymorphism was significantly correlated to lower STAI sum scores as well as higher
MAAS scores. No other significance was observed, though sample selection and a lack of a
‘healthy’ control group may have been contributing factors to our lack of findings.
The Bcl1 mutation is one of the most commonly investigated SNPs in relation to GR
activity. The mutation at this location, a C to G substitution, is common among the population
and therefore simplifies the ability to compare across genotypes. The G allele is associated with
lower cortisol levels due to an overactive GR, whereas the C allele is correlated with elevated
cortisol both before and after stressful tasks (Ising et al., 2008; Van Rossum et al., 2003). The
allelic frequencies in our study were similar to those observed in the world population, and we
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found no correlation between genotypes of the Bcl1 allele and any of the depression or anxiety
inventories used in our study. Inventory scores between the WT and Hetero/MU groups did not
approach significance for any scale, and standard deviations for genotype groups were large
across scales.
The TthIII mutation on the GR gene has shown differing effects across studies. Moriaitis
et al. found that carriers of the TthIII polymorphism in their study also carried the ER22/23EK
mutations, and these individuals displayed elevated levels of cortisol due to GR resistance
(2016). Contrastingly, a study by Van Rossum and Lamberts consisted of individuals who were
carriers of ER22/23EK but not TthIII, and reported no correlation between the TthIII
polymorphism alone and cortisol sensitivity, whereas the ER22/23EK polymorphism
demonstrated an association with elevated cortisol levels (2004). Our study did not reveal a
correlation between the presence of the TthIII mutation and inventory scores measuring
depression or anxiety. This is seemingly in accordance with Van Rossum and Lamberts, as a lack
of association with depressive symptoms may indicate a lack of abnormality in cortisol
sensitivity by the GR. Because our study did not genotype for the ER22/23EK polymorphisms, it
is impossible to deduce whether the patients in our study had these mutations as well. Further
study into TthIII and its association with the ER22/23EK polymorphism and cortisol sensitivity
is required to determine the effects of the mutation.
The N363S mutation has been predominantly recorded as causing increased sensitivity to
cortisol, although some studies have demonstrated a resistance to cortisol or no effects on
cortisol sensitivity (Moraitis et al., Ising et al., 2008). Our study found no effect of the mutation
on inventory scores. Only three patients had a mutation in at least one allele in the N363S
position, and this lack of genotypic diversity may have contributed to the lack of findings. Ising
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et al. had no participants with a mutant genotype of N363S in their sample and only 14% of
participants demonstrated a heterozygous genotype. They did not find any association between
the mutation and cortisol sensitivity (2008). The world frequency for this SNP is not recorded,
but it is likely that the mutation is very infrequent, creating difficulty in studying it.
Rs3389 and rs105 are the least studied polymorphisms of our study. Plieger et al.
constructed a haplotype, which consisted of the minor allele of rs33389 and the major allele of
rs10515522, and demonstrated that patients with this haplotype had elevated cortisol following a
stress test (2017). Therefore, the rs33389 mutation likely has a hyposensitivity effect (elevated
cortisol), while the minor allele of rs105 likely has a hypersensitivity effect (low cortisol levels).
Although no significance was found correlating rs105 with any inventory, a one-tailed
significance was found between the rs33389 minor allele and ACE sum scores. Resistance to
cortisol was associated with higher ACE scores; patients with suspected elevated cortisol levels
demonstrated more adverse childhood experiences. Prolonged exposure to stress has shown to
alter HPA axis functioning, and past studies investigating the epigenetic effects of adverse
childhood experiences on the cortisol response demonstrated evidence of blunted as well as
elevated cortisol sensitivity (Tyrka et al., 2016). Tyrka et al. showed that adults who had
experienced parental death or desertion as children exhibited elevated cortisol responses to
pharmacological agents made to evaluate HPA function, while Carpenter et al. found that adult
participants who had experienced childhood emotional abuse showed lower, or blunted, cortisol
levels following a pharmacological agent (2009). The epigenetic mechanism of methylation has
been linked to the alteration in HPA axis function, most notably methylation of the GR gene
NR3C1 (Tyrka et al., 2016). The mutation is not a causal factor in epigenetic alteration, but the
combination of both a mutation causing hyposensitivity and epigenetic changes from adverse
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childhood experiences would suggest higher depressive symptoms, though this was not observed
in our sample. Alternatively, if Carpenter et al.’s finding of lowered cortisol levels following
emotional abuse in childhood were to be observed in our sample rather than Tyrka et al.’s
elevated cortisol finding, the mutation and the epigenetic changes could theoretically cancel out
any observed effect on HPA axis functioning.
Although not on the GR gene, the rs120 polymorphism, located on the 11β-HSD1 gene
which regulates the conversion of the inactive form cortisone to active cortisol, was investigated
due to previous literature demonstrating its effect on circulating cortisol levels. The major allele
of the rs120 polymorphism has been associated with elevated cortisol levels (Farang et al. 2019).
The minor allele has demonstrated a reduction in function and a protective effect against elevated
cortisol levels (Deak, 2016). Therefore, the major allele mimics the impact of Cushing’s
syndrome: elevated cortisol without an alteration in GR functioning. The WT allele of rs120 was
significantly correlated with higher STAI sum scores. Because the WT allele is associated with
elevated cortisol, this result demonstrates that elevated cortisol levels with (seemingly) normal
functioning GR and MR receptors is correlated with heightened anxiety. Adults with anxiety
have been correlated with significantly higher cortisol levels, and drugs reducing cortisol
production have shown to improve anxiety (Lenze et al., 2012). Our results support this claim of
elevated cortisol levels as a risk factor for anxiety. Depression and anxiety are often observed to
occur together and share many common symptoms and treatments (Sawchuk, 2017). Though
seemingly similar, no correlation between rs120 genotypes and BDI scores was observed.
The rs120 polymorphism was also significantly correlated with higher MAAS scores.
The MAAS scale measures mindfulness and awareness and multiple studies have demonstrated it
is inversely correlated to the BDI and BDI-II scales (Brown and Ryan, 2003; Barajas and Garra,
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2013). Our result suggests that individuals with a mutation leading to lower cortisol levels are
associated with higher mindfulness and awareness. This is in agreement with our earlier finding
of the rs120 major allele correlating with increased anxiety as the major allele was also
associated with significantly lower mindfulness and awareness scores. Our result further supports
elevated cortisol levels as risks for depression, and lowered cortisol as a potential protective
factor (Deak, 2016; Lenze et al., 2012).
The rs207 and rs5522 polymorphisms have been demonstrated, within a larger haplotype
consisting of the rs207 minor allele and rs5522 major allele, to cause an increase in MR activity
(Klok et al. 2011). Studies investigating the role of MR function in the HPA axis have
demonstrated an increase in MR activity as a protective factor against depression, showing
evidence for improved resilience and fewer thoughts of hopelessness, especially in females
(Klok et al. 2011). Contrastingly, other studies observed no difference in the cortisol stress
response for carriers of the rs207 or rs5522 polymorphisms (Bouma et al., 2011; Ising et al.,
2008). Our study did not demonstrate any significant correlation between either individual
polymorphism and inventory scores. It is important to note that the rs5522 mutant frequency is
very low in the world population (~14%) and was even lower in our sample (~5%), creating a
difficulty in analyzing differences between groups. Other studies have also demonstrated this
lack of genotypic diversity of rs5522, creating limited groups for comparison (Ising et al., 2008).
Our results are therefore both in agreement and disagreement with past research, highlighting the
importance of further research of the role of MR activity on cortisol levels and depressive
symptoms.
The final individual SNP studied was rs1360780, or FKBP51a. This polymorphism is
located on the FKBP5 gene, a protein regulating GR activity. The minor allele has shown effects

Genetic Predisposition to Depression

22

of impaired cortisol recovery as well as increased cortisol levels during recovery following the
administration of trier social stress tests (Binder et al., 2004; Ising et al., 2008). Our study found
no significant correlation between the FKBP51a and any inventory scores.
Cortisol levels in our participants were not measured at a consistent time over a period of
sessions, and we therefore did not include cortisol levels into our analysis. Our basis of the
altered sensitivities of cortisol due to the studied mutations arose from previous research that
measured cortisol levels at distinct times throughout the day or before and following labadministered stress tests. Future studies in our lab hope to conduct both genotype analysis and
accurate cortisol measurements from participants to first compare the mutations with cortisol
levels and determine if our sample shows significant correlations, and then investigate inventory
scores of those participants with altered cortisol sensitivities.
Further studies should also focus on diversifying the sample of patients in terms of their
psychiatric histories. A BDI score of 29-63 is considered severe, and although standard
deviations were large, the lowest BDI mean in our sample for any genotype across SNPs was
28.28 (rs120 Hetero and MU group). Only seven of our 40 patients who filled out the BDI
displayed minimal to moderate depression. Therefore, within all groups there were patients
displaying high numbers of depressive symptoms. Further analysis including a larger subset of
‘healthy’ patients as a control group may yield a larger diversity of BDI scores and subsequently
more difference between the genotype groups. The same pattern was observed with the STAI
scale: STAI sum scores range from 40 to 160 and all our group averages were over 100. The
ACE scores in our sample, on a scale from 1 to 10, had a low of 2.50 and most scores were in the
3-5 range. The CDC ACE study found only 20% of people had an ACE of 3 or more,
demonstrating a skew in our study towards higher childhood abuse (CDC, 1998). MAAS scores
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were more equally distributed and representative of other study populations (Carlson and Brown,
2004). A larger sample size would also provide better analysis by allowing genotype groups to
be larger and introducing the possibility of comparing three genotype groups rather than two.
This increased sample size and increased diversity mentioned above would improve our chances
of identifying the possible effects of mutations.
Although many of our previous studies investigated the effects of individual SNPs on
depressive symptoms, a plethora of academic studies have constructed haplotypes consisting of
multiple SNPs, thereby studying the effects of a culmination of mutations. Because the GR and
MR both respond to and translate the effects of cortisol in our bodies, we aimed to investigate if
an interplay between malfunctioning of the receptors could be responsible for altered response to
cortisol, and in turn, lead to depressive symptoms. The interaction of MR and GR is crucial for
moderating the body's response to stress, and previous research has shown that alterations in the
MR:GR ratio may have implications for depression and other cognitive functions, though the
interaction between the receptors has not been fully characterized (Gomez-Sanchez and GomezSanchez, 2015; Rivers et al., 2019). By characterizing the apparent effect of hypo and hyper
sensitivity for each receptor, we theorized outcomes that would occur when combining
polymorphisms for the receptors (Figure 11).
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Figure 11. Activity of the GR and MR and combined effects. The first symbol in each
box represents GR activity, the second represents MR activity. A “/” represents normal activity,
whereas a “+” is hyperactivity and a “-” is hypoactivity (resistance).

Boxes including normal activity for one receptor are represented by individual SNPs of
the other receptor mentioned earlier in the study (for example, normal MR and resistant GR is
demonstrative of the TthIII or rs33389 polymorphism). Of interest are the boxes representing
mutations in both receptors. If both receptors are hyperactive (top right box), there would be low
cortisol levels due to increased activity of the GR and more negative feedback, but an overactive
MR would theoretically ‘compensate’ for low levels by binding more cortisol. In addition, the
MR is normally occupied at low, basal levels of cortisol so lower circulating levels would likely
not have strong negative effects. On the other end, resistance (hypoactivity) in both receptors
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(bottom left box) would create elevated levels of circulating cortisol because of less negative
feedback from the GR, but the MR resistance would prevent it from being overwhelmed by high
circulating levels, essentially ‘canceling out’ any negative effect. Because of the theoretical
compensating interaction between receptors, we did not investigate these combinations. Rather,
we studied combinations of hypersensitivity and resistance. A resistant GR leading to elevated
cortisol levels paired with a hypersensitive MR (bottom right box) would create significantly
increased activity at the MR due to the increased availability of cortisol. On the other end, an
overactive GR leading to low cortisol levels paired with a resistant MR (top left box) would
potentially restrict the MR’s ability to bind to cortisol, and be less occupied even at basal levels
when cortisol is normally bound. Therefore, the GR feedback mechanisms influencing MR
activity, in addition to the effects observed in the GR when feedback is altered, cause a
dysregulation in both receptors.
Of the six SNP combinations studied, we did not observe any correlation between
genotype groups and inventory scores. Our small sample size and limited genetic diversity for
many SNPs prevented us from comparing many SNP combinations because the mutant
haplotype groups contained no patients. Of the mutant haplotype groups that did have
participants, their sample size of one to two patients also limited our comparison analysis and
introduced high probabilities of error.
The combinations of SNPs developed in this study were purely theoretical based on an
integration of results obtained from previous research. The interaction between the GR and MR
has not been investigated to the same extent as individual polymorphisms and further
physiological research is required to grasp the nature of the interaction between the receptors.
The differing binding affinities of the receptors, as well as the potential protective effects of
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certain MR mutations likely play integral roles in this interaction. Understanding the interaction
will better allow us to discern how mutations in one or both receptors alters function in the other,
and ultimately aid in creating functional haplotypes for further research.
In conclusion, our study demonstrated one-tailed significance for two mutations in which
elevated cortisol levels correlated to higher anxiety and childhood abuse, as well as lower
mindfulness. No significance was found between haplotypes and inventory scores. Further
research with larger and more diversified samples, as well as a deeper mechanistic understanding
of receptor interactions, are the necessary next steps to understanding the role of genetic
mutations in HPA axis functioning. A greater grasp on causes of dysregulation of the HPA axis
and mishandling of stress will better aid in research for therapeutic drugs aimed at alleviating
symptoms of depression and anxiety.
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Appendix 1. Methods
Protocol 1. DNA Collection and Extraction, from Team Cohen Master Lab Manual
DNA Collection
1) Rub the brush on the inside of the mouth for 15-30 sec.
2) Remove the swab handle and put the brush section of the swab inside a 1.5 mL
microcentrifuge tube.
3) If not proceeding directly to DNA extraction, store swabs at 4oC.
DNA Extraction
1) Add 600 µL of 50 mM NaOH.
2) Close the tube containing the brush and vortex for 10 min.
3) Heat the tube at 95°C for 10 min.
4) Add 120 µL 1 M Tris (pH 8.0) to the tube and remove and discard the brush.
5) Centrifuge 1 min at max speed and transfer the supernatant to a new tube.
6) Store the DNA at 4°C.
7) Between 2 and 10 µL of this biosample is used in a typical PCR reaction.
Protocol 2. Chelex Cleanup Prep
1) Pipette 200 µL of DNA into a microfuge tube.
2) Resuspend Chelex beads by vortexing for 10 seconds.
3) pipette 500 µL of Chelex solution into the microfuge tube containing the DNA.
4) Mix DNA with the Chelex by vortexing for 10 seconds.
5) Incubate the microfuge tube containing the DNA/Chelex mixture in the boiling water
bath for 10 minutes.
6) Incubate it on ice for two minutes.
7) Spin the tube in a microfuge (max. speed) for 1 minute to pellet the Chelex and debris to
the bottom of the tube.
8) Transfer supernatant to a new microfuge tube.
Protocol 3. Allelic PCR, adapted from Qiagen Master Mix sheet
1) Collect 2 PCR tubes per DNA sample.
2) Label PCR tubes by numbering them with sharpie.
3) In your Qiagen Master Mix sheet, input the number of reactions (2 per sample) plus two
under mix 1.
4) Record your templates according to their number label in the google sheet
5) Vortex each DNA sample and pipette 2ul of template into each PCR tube (2
tubes/reactions per sample)
6) Collect three microfuge tubes. In two separate tubes, pipette the WT and MU primers
7) In the other microfuge tube, make mix 1 based on the measurements on the Qiagen
master mix sheet, adding Taq last. Vortex after each addition.
8) Equally split the master mix into the WT and MU microfuge tubes. Vortex microfuge
tubes
9) Pipette 13ul of WT mix into odd-numbered PCR tubes
10) Pipette 13ul MU mix into even-numbered PCR tubes
11) Place tubes in PCR machine and lock the lid
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12) Select appropriate PCR protocol from Team Cohen folder according to correct annealing
temperature
13) Once the PCR reaction is complete, samples can be stored in the fridge if a gel is not run
directly afterwards.
Protocol 4. Gel Electrophoresis, from Team Cohen Master Lab Manual
Assembling the gel box
1) Turn the gel box so the electrodes are facing you.
2) Place the gel tray into the box perpendicular to the box so that the rubber gaskets on the
side seal along the edge of the box.
3) There are 2 notches for the combs- make sure one set of notches is on the far side of the
gel box and one set is closer to you in the middle.
Making the gel
1) Measure 100ml 1X PE with a graduated cylinder and place in a 500ml Erlenmeyer flask.
2) Add 2g of agarose.
3) Swirl, then microwave (for the microwave in WLDC201 microwave for 1 minute and 15
seconds).
4) Remove from microwave with a hot glove, hold up to the light and swirl to make sure
everything is dissolved.
Pouring the gel
1) When the gel has cooled slightly, pour into the gel tray.
2) Place two 20-well combs into the tray- one comb should be on the far side of the gel and
the other comb in the middle. Both should be pointing to 1.5mm.
3) Allow the gel to solidify.
4) Immediately wash the flask out with hot water.
Running the gel
1) When the gel has solidified, turn the gel perpendicularly so that the comb that was on the
far side is now on the left.
2) Add sufficient 1XPE to the gel box so that the gel is completely submerged.
3) Pipette 3ul of dye into each sample.
4) Load samples onto the gel and slide the lid on.
5) Connect the electrodes to the power supply.
6) Press the set button and check the current settings. Set volts to 100V by pressing Set
button on right side of the power box and adjusting the volts dial.
7) Press the start button and the light labeled DC should come on.
8) Let gel run until dye has moved to the end of the lanes.
Visualizing the gel
1) Turn off the voltage and remove the gel from the box.
2) Bring the gel with the container to the imaging instrument.
3) Open the drawer and place the gel on the glass. Close the drawer and use the door to
reposition the gel as needed.
4) On the computer next to the imager, go to image lab then click the file tab, click on recent
protocols and choose Ethidium Bromide.
5) Click the yellow position gel button and position your gel so that all 20 lanes are visible.
6) Once the gel is in place, shut the door and click run protocol.
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Figure 4. Imaged Gel Feb 2, 2021 for the rs207 SNP, with lanes labeled 1-14. Pairs of two lanes
represent one sample (ex. Lanes 1 and 2 represent the same DNA of sample 1). Lanes 7 and 14
are 100 base pair ladders. The expected product size for the rs207 bands are 180bp. Presence of a
band in lanes 1, 3, and 5 signify a WT genotype for samples 1, 2, and 3.
Protocol 5. qPCR, adapted from qPCR Master Mix sheet
Preparing the reaction tubes
1. Ideally, run reactions with 7, 15, or 8n-1 ≤ 96 number of samples (with n being any
whole integer)
2. Collect appropriate number of qPCR tube racks
3. Open qPCR master mix sheet and input the number of reactions under mix 1 (one
reaction per sample)
4. In a centrifuge tube, make mix 1 according to the measurements on the Master mix sheet
5. Pipette 2ul template into each reaction tube, and pipette 2ul water into last tube (to serve
as negative control)
6. Pipette 8ul mix into each tube, including negative control
7. Centrifuge tubes in centrifuge machine next to qPCR instrument, making sure to use
another empty tube holder as a balance
Running the qPCR
1. Open quantstudio
2. Open existing experiment > desktop > experiments > Cohen lab > templates > choose
Cohen standard
3. Change experiment name (date, snp)
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4. Fill in plate layout (plate tab)
a. Drag and select
b. Snp assay > one
c. Double click negative control, mark SNP as no template control
d. Hit next
5. Turn instrument on (power switch on the back)
6. Open instrument drawer (top right button)
7. Place tubes where you assigned on plate layout
8. Click start run on quantstudio (computer)
9. Save result outside of template folder (in Cohen lab folder)
a. Date, name, snp
10. When run is complete, Login to account on screen of instrument and save to your cloud

Figure 5. Allele Amplification Multicomponent Plot from ThermoFisher QuantStudio for 5 DNA
samples. Blue and Green lines represent allele amplifications based on fluorescence values (blue:
WT, green: MU). Each sample has one blue and one green line. The red line represents the
negative control (no amplification) value. Ratios of WT:MU fluorescence were utilized to
determine the sample genotype, pictured in Figure 6 below.
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Figure 6. Allele Discrimination Plot corresponding to the above Multicomponent Plot. The
sample consisted of two heterozygous samples (green) and two wildtype samples (blue). Omitted
samples are those that were not pictured in the amplification plot and are therefore not correlated
to Figure 5.
Appendix 2. Results Tables/Figures
Allelic Frequencies

Figure 7. Genotypic Frequencies by percentage for investigated SNPs in the sample population.
1: WT, 2: Hetero, 3: MU
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SNP

Allele

Sample
Frequency

World
Frequency

WT

0.643

0.661

MU

0.357

0.339

WT

0.963

N/A

MU

0.037

N/A

WT

0.724

0.692

MU

0.276

0.308

WT

0.881

0.516

MU

0.119

0.484

WT

0.950

0.886

MU

0.050

0.114

WT

0.829

0.589

MU

0.171

0.411

WT

0.853

0.869

MU

0.147

0.131

WT

0.793

0.583

MU

0.207

0.417

WT

0.722

0.686

MU

0.278

0.315

Bcl1

N363S

TthIIIi

Rs207

Rs5522

Rs105

Rs33389

RS120

Fkbp51a

Table 2. Allelic Frequencies of the sample population compared to allelic frequencies of world
and European populations for the investigated SNPs. World Frequency data was collected from
the NCBI dbSNP library.
Individual SNP Analysis
SNP

Groups

N

Mean BDI

P value
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WT

16

29.13 ± 16.370

Hetero + Mu

23

33.26 ± 14.906

WT

35

30.89 ± 15.480

Hetero + Mu

3

38.00 ± 19.519

WT

23

34.04 ± 15.850

Hetero + Mu

12

30.17 ± 15.736

WT

16

32.88 ± 16.820

Hetero + Mu

3

31.00 ± 5.000

WT

26

31.31 ± 14.664

Hetero + Mu

1

54

WT

23

32.78 ± 16.382

Hetero + Mu

9

32.78 ± 15.514

WT

25

29.64 ± 16.817

Hetero + Mu

7

35.29 ± 10.858

WT

20

33.25 ± 17.935

Hetero + Mu

18

28.28 ± 11.007

WT

19

29.84 ± 14.815

Hetero + Mu

14

30.43 ± 15.535

Bcl1

N363S

TthIIIi

Rs207

Rs5522

0.418

0.457

0.496

0.853

0.141

Rs10515522

Rs33389

RS120

FKBP51a

0.999

0.410

0.316

0.913

Table 3. Comparison of genetic associations with BDI scores between WT and MU alleles.
Hetero and MU genotypes combined due to small N and the presence of a MU allele in both
genotypes. No significant correlation between any SNP and BDI score was found in the study
sample.

SNP

Groups

N

Mean STAI sum

P value

Bcl1

WT

15

106.47 ± 20.511

0.405
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Hetero + Mu

19

113.11 ± 24.433

WT

31

109.19 ± 22.699

Hetero + Mu

3

120.33 ± 24.583

WT

19

112.68 ± 22.770

Hetero + Mu

12

108.42 ± 24.028

WT

16

111.38 ± 27.264

Hetero + Mu

4

111.75 ± 7.274

WT

23

108.39 ± 24.666

Hetero + Mu

3

119.00 ± 7.00

WT

22

107.15 ± 22.346

Hetero + Mu

8

120.00 ± 22.399

WT

22

105.77 ± 24.999

Hetero + Mu

6

122.00 ± 15.761

WT

17

115.41 ± 21.754

Hetero + Mu

16

102.38 ± 21.150

WT

16

107.25 ± 23.605

Hetero + Mu

15

110.33 ± 22.896

N363S

TthIIIi

Rs207

Rs5522

Rs10515522

Rs33389

RS120

Fkbp51a

0.425

0.622

0.979

0.473

0.209

0.146

0.091

0.715

Table 4. Comparison of genetic associations with summed STAI scores between WT and MU
alleles. Hetero and MU genotypes combined due to small N and the presence of a MU allele in
both genotypes. No significant correlation between any SNP and STAI sum score was found in
the study sample.

SNP

Groups

N

Mean ACE sum

WT

13

4 ± 3.109

Hetero + Mu

10

4.50 ± 2.718

Bcl1

P value

0.691
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WT

20

3.95 ± 2.665

Hetero + Mu

3

6.00 ± 4.359

WT

13

3.85 ± 2.940

Hetero + Mu

10

4.70 ± 2.908

WT

12

3.101 ± 0.869

Hetero + Mu

2

2.50 ± 2.12

WT

16

4.31 ± 3.049

Hetero + Mu

2

4.00 ± 2.828

WT

17

4.06 ± 2.989

Hetero + Mu

4

4.00 ± 2.944

WT

16

3.81 ± 3.038

Hetero + Mu

4

7.00 ± 0.816

WT

13

4.31 ± 2.780

Hetero + Mu

9

3.56 ± 2.833

WT

13

3.38 ± 2.663

Hetero + Mu

8

4.88 ± 3.182

N363S

0.262

TthIIIi

0.495

Rs207

0.564

Rs5522

0.893

Rs10515522

0.972

Rs33389

0.056

Rs120

0.543

Fkbp51a

0.261

Table 5. Comparison of genetic associations with summed ACE scores between WT and MU
alleles. Hetero and MU genotypes combined due to small N and the presence of a MU allele in
both genotypes. No significant correlation between any SNP and ACE sum score was found in
the study sample.

SNP

Groups

N

Mean MAAS

WT

14

48.93 ± 22.293

Hetero + Mu

15

48.27 ± 12.435

WT

25

50.20 ± 15.927

Bcl1

N363S

P value

0.921

0.401
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Hetero + Mu

3

41.00 ± 31.575

WT

16

46.69 ± 15.589

Hetero + Mu

11

50.55 ± 21.993

WT

12

50.75 ± 21.541

Hetero + Mu

2

47.50 ± 2.121

WT

20

49.15 ± 16.762

Hetero + Mu

2

28.00 ± 7.071

WT

20

49.15 ± 18.639

Hetero + Mu

7

50.29 ± 16.183

WT

20

51.40 ± 19.478

Hetero + Mu

6

44.00 ± 12.442

WT

15

44.00 ± 13.711

Hetero + Mu

13

56.23 ± 18.226

WT

16

52.06 ± 18.068

Hetero + Mu

9

47.78 ± 18.397

TthIIIi

0.598

Rs207

0.84

Rs5522

0.098

Rs10515522

0.887

Rs33389

0.392

Rs120

0.053

Fkbp51a

0.577

Table 6. Comparison of genetic associations with MAAS scores between WT and MU alleles.
Hetero and MU genotypes combined due to small N and the presence of a MU allele in both
genotypes. No significant correlation between any SNP and MAAS score was found in the study
sample.
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Figure 8. Comparison of STAI sum scores between WT and MU alleles of rs120. WT allele was
significantly correlated with higher STAI sum scores in a one-tailed test (t(31)= -1.74, p=0.046).

Figure 9. Comparison of ACE sum scores between WT and MU alleles of rs33389. WT allele
was significantly correlated with lower ACE sum scores in a one-tailed test (t(18)= 2.04 , p=
0.0281).
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Figure 10. Comparison of MAAS scores between WT and MU alleles of rs120. WT allele was
significantly correlated with lower MAAS scores in a one-tailed test (t(31)= 2.02, p=0.027).
SNP Combination Analysis
Combination

Effect of GR SNP

Effect of MR SNP

Bcl1 and rs55

Hypersensitivity

Hyposensitivity

TthIII and rs207

Hyposensitivity

Hypersensitivity

rs333 and rs207

Hyposensitivity

Hypersensitivity

N363S and rs55

Hypersensitivity

Hyposensitivity

rs105 and rs55

Hypersensitivity

Hyposensitivity

FKBP51a and rs55

Hypersensitivity

Hyposensitivity

Table 7. Investigated SNP combinations and associated (opposing) effects on the GR and MR
proteins of the HPA axis.
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Combination

Group

N

Mean BDI

1

27

32.15 ± 15.027

2

0

N/A

1

17

33.06 ± 16.304

2

2

28.50 ± 3.536

1

16

30.38 ± 15.331

2

0

N/A

1

26

32.00 ± 15.305

2

0

N/A

1

23

33.22 ± 15.338

2

0

N/A

1

24

30.71 ± 15.098

2

1

54

Bcl and rs55

Sig

N/A

TthIII and rs207

rs207 and rs333

0.705

N/A

N363S and rs55

N/A

rs55 and rs105

N/A

FKBP51a and rs55

0.144

Table 8. Comparison of BDI scores between haplotypes of investigated SNP combinations.
Group 1 represents at least one WT genotype of both SNPs (i.e. WT for both Bcl1 and rs55, or
WT for Bcl1 and Hetero or Mu for rs55 and vice versa), whereas Group 2 represents both SNPs
having a Hetero or Mu genotype.

Combinations

Group

N

Mean STAI sum

1

25

109.56 +/- 23.962

2

1

111

1

18

111.56 +/- 25.624

2

2

110.50 +/- 12.021

1

16

109.94 +/- 26.479

2

0

N/A

Bcl and rs55

Sig

0.953

TthIII and rs207

0.956

rs207 and rs333

N/A
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1

26

109.62 +/- 23.479

2

0

N/A

1

22

110.36 +/- 24.242

2

1

111

1

23

108.35 ± 24.637

2

2

116.50 ± 7.778

N363S and rs55

N/A

rs55 and rs105

0.98

FKBP51a and rs55
0.651

Table 9. Comparison of summed STAI scores between haplotypes of investigated SNP
combinations. Group 1 represents at least one WT genotype of both SNPs, whereas Group 2
represents both SNPs having a Hetero or Mu genotype.

Combinations

Group

N

Mean ACE sum

1

18

4.28 ± 2.947

2

0

N/A

1

13

3.62 ± 2.987

2

1

4

1

11

3.91 ± 3.177

2

0

N/A

1

18

4.28 ± 2.947

2

0

N/A

1

17

4.06 ± 2.883

2

0

N/A

1

17

4.41 ± 2.980

2

1

2

Bcl and rs55

P value

N/A

TthIII and rs207

0.903

rs207 and rs333

N/A

N363S and rs55

N/A

rs55 and rs105

N/A

FKBP51a and rs55

0.786

Table 10. Comparison of summed ACE scores between haplotypes of investigated SNP
combinations. Group 1 represents at least one WT genotype of both SNPs, whereas Group 2
represents both SNPs having a Hetero or Mu genotype.
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Combinations

Group

N

Mean MAAS

1

22

47.23 ± 17.185

2

0

N/A

1

13

50.62 ± 20.630

2

1

46

1

11

53.36 ± 21.341

2

0

N/A

1

21

48.00 ± 17.213

2

0

N/A

1

21

48.14 ± 17.051

2

2

N/A

1

19

48.68 ± 17.777

2

1

33

Bcl and rs55

P value

N/A

TthIII and rs207

0.833

rs207 and rs333

N/A

N363S and rs55

N/A

rs55 and rs105

N/A

FKBP51a and rs55

0.86

Table 11. Comparison of MAAS scores between haplotypes of investigated SNP combinations.
Group 1 represents at least one WT genotype of both SNPs, whereas Group 2 represents both
SNPs having a Hetero or Mu genotype.
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